Chen Duksin, MD, MBA

Chief Medical Officer
Ayala Pharmaceuticals

Chen Duksin, MD, MBA is a biopharmaceutical executive with over 14 years of experience in the Pharmaceutical Industry in both Medical Affairs and Clinical Development.  Most recently, Chen served as Medical Affairs Director at Janssen Israel, where he supported the launch of key products across various therapeutic areas including Hemato-Oncology, Prostate Cancer and Inflammatory Bowel Disease. Prior to Janssen, Chen was the Medical Director at Bayer Israel, where he built the medical and regulatory department at a newly established affiliate. Before that he held a role as Associate Director, Global Clinical Development at Teva’s Innovative R&D division, where he was the clinical lead on several global clinical trials in all clinical phases in both Oncology and Neurology. Chen is a board-certified physician in Obstetrics and Gynecology, and earned his MD from the Hadassah Medical School of the Hebrew University in Jerusalem, as well as an MBA from the IDC in Herzliya, Israel.